Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-043967

General Counsel sold 712 shares at $15.67 ($11,157)

  • General Counsel acquired 1,924 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ring Christine General Counsel 2022-07-30 Option exercise +1,924 5,327 D: show line 1 in the form
Ring Christine General Counsel 2022-08-01 Sale −712 $15.67 $11,157 4,615 D: show line 2 in the form
Open-market sales · 712 sh · avg $15.67 · $11,157

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ring Christine General Counsel 2022-07-30 Option exercise · Restricted Stock Units −1,924 26,937 D: show line 3 in the form
Loading xslF345X03/doc4.xml…